- Previous Close
22.93 - Open
22.50 - Bid 22.78 x --
- Ask 22.80 x --
- Day's Range
22.45 - 22.98 - 52 Week Range
13.15 - 24.50 - Volume
5,530,153 - Avg. Volume
10,088,480 - Market Cap (intraday)
21.083B - Beta (5Y Monthly) -0.03
- PE Ratio (TTM)
18.39 - EPS (TTM)
1.24 - Earnings Date --
- Forward Dividend & Yield 0.38 (1.66%)
- Ex-Dividend Date May 28, 2024
- 1y Target Est
--
Chengdu Kanghong Pharmaceutical Group Co., Ltd research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China. It also develops ophthalmic medical devices. The company offers central nervous, digestive, and endocrine system drugs. Chengdu Kanghong Pharmaceuticals Group Co., Ltd. was founded in 1996 and is based in Chengdu, China.
www.cnkh.com4,289
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 002773.SZ
Performance Overview: 002773.SZ
Trailing total returns as of 6/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002773.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002773.SZ
Valuation Measures
Market Cap
21.08B
Enterprise Value
16.02B
Trailing P/E
18.34
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.02
Price/Book (mrq)
2.58
Enterprise Value/Revenue
3.85
Enterprise Value/EBITDA
12.59
Financial Highlights
Profitability and Income Statement
Profit Margin
27.34%
Return on Assets (ttm)
8.93%
Return on Equity (ttm)
14.65%
Revenue (ttm)
4.17B
Net Income Avi to Common (ttm)
1.14B
Diluted EPS (ttm)
1.24
Balance Sheet and Cash Flow
Total Cash (mrq)
5.06B
Total Debt/Equity (mrq)
0.02%
Levered Free Cash Flow (ttm)
837.43M